Beryl Drugs Approves Q2 FY27 Unaudited Financial Results
Beryl Drugs Ltd 路 Outcome 路 14 Nov 2026, 9:34 pm
Beryl Drugs Approves Q2 FY27 Unaudited Financial Results Beryl Drugs Limited announced that its Board of Directors met on 14th Nov'26 to consider and approve the company's unaudited financial results for the quarter ended 30th Sep'26. Additionally, the Board officially took on record the Limited Review Report submitted by the statutory auditors for the same period.
Original exchange filing (PDF)
More announcements from Beryl Drugs Ltd
- UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30.09.2026 路 14 Nov 2026
- Beryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve to consider and approve unaudited .... 路 14 Nov 2026
- NON- APPLICABILITY CERTIFICATE UNDER REGULATION 57(5) FOR THE QUARTER ENDED 30.09.2026 路 08 Oct 2026
- VOTING RESULTS OF 33RD ANNUAL GENERAL MEETING HELD ON 29TH SEPTEMBER, 2026 路 01 Oct 2026
- PROCEEDINGS OF 33RD ANNUAL GENERAL MEETING 路 29 Sept 2026
- considered and approved the increase in limit of material related party transactions with M/S. AMINOVA INFUSIONS PVT. LTD. 路 29 Sept 2026
- OUTCOME OF 33RD ANNUAL GENERAL MEETING 路 29 Sept 2026
- ANNUAL REPORT 2025-2026 路 04 Sept 2026
